These findings suggest that targeting HLA-E and senescent cancer cells could restore anti-tumor immunity by correcting lymphoid dysregulation, offering potential therapeutic strategies for lung cancer with pleural metastasis. This evidence concerns the gene HLA-E and lung carcinoma.